The most common breast cancer subtypes were hormone receptor-positive (HR+) HER2-negativ in 14 (46.7%) and triple-negative had triple-negative (HR-HER2−) in 10 (33.3%). This evidence concerns the gene ERBB2 and breast carcinoma.